2 CKD confirmatory secondary endpoints Significant 18% RRR of MACE with Ozempic 2 For adults with T2D and CKD, for a confirmatory secondary endpoint: Time to first occurrence of MACE (CV death, nonfatal MI, or nonfatal stroke) vs placebo when both were added to standard of care 1,2 Time to first MACE 1-3,w-z 1-3,w-z w Cumulative incidence estimates are based on time from randomization to first EAC-confirmed MACE with non-CV death modelled as a competing risk using the Aalen-Johnson estimator
Most side effects of Wegovy are mild to moderate, especially at the beginning of treatment, and tend to improve as your body adjusts
Treatment Efficacy Evaluation: AI helps in evaluating treatment efficacy in real-world settings, providing insights into how drugs perform outside clinical trials
Two glutamate- and pH-regulated Ca(2+) channels are required for systemic wound signaling in Arabidopsis
To learn more, head to dermapure.com/en
Western blots were performed on three animals per group except as otherwise indicated in the figure legend